eye Insights 14: Genetic Therapies for Inherited Retinal Disorders

Eye Insights 14
While gene therapy is not yet widely available for inherited retinal disorsers (IRDs), researchers are making exciting discoveries, and the future looks more promising than ever before. In this issue of eye Insights, we provide a look into current offerings in gene therapy, and a glimpse into the exciting prospects brought forth by clinical trials being led by our own researchers at Mass Eye and Ear.

 

Inside 

  • IRDs and genetic testing
  • Current gene therapies for IRDs
  • Access to clinical trials
  • Treatment and outcomes

Editor-in-Chief: Joan W. Miller, MD 
Managing Editor: Matthew F. Gardiner, MD
Clinical Advisory Group: Deeba Husain, MD; Alice Lorch, MD, MPH; Ankoor Shah, MD, PhD
Publications Manager: Jessica O’Donnell 
Graphic Design: Stone Studio Design
Contributor: Rachel M. Huckfeldt, MD, PhD

Browse all issues > >    |    Email: eyeinsights@meei.harvard.edu

See also: